Breaking News Instant updates and real-time market news.

BA

Boeing

$380.17

2.63 (0.70%)

, I

Intelsat

$19.38

0.14 (0.73%)

16:01
04/18/19
04/18
16:01
04/18/19
16:01

Intelsat says anomaly resulted in total loss of Intelsat 29e spaceraft

Intelsat S.A. (I) announced that the anomaly previously disclosed on April 10, 2019 has resulted in the total loss of the Intelsat 29e spacecraft. A failure review board has been convened with the satellite's manufacturer, Boeing (BA), to complete a comprehensive analysis of the cause of the anomaly. Late on April 7, the Intelsat 29e propulsion system experienced damage that caused a leak of the propellant on board the satellite resulting in a service disruption to customers on the satellite. While working to recover the satellite, a second anomaly occurred, after which all efforts to recover the satellite were unsuccessful. Since the anomaly, Intelsat has been in active contact with affected customers. Restoration paths on other Intelsat satellites serving the region and third-party satellites have been provided for a majority of the disrupted services.

BA

Boeing

$380.17

2.63 (0.70%)

I

Intelsat

$19.38

0.14 (0.73%)

  • 24

    Apr

  • 29

    Apr

  • 29

    May

  • 05

    Jun

BA Boeing
$380.17

2.63 (0.70%)

04/09/19
GSCO
04/09/19
NO CHANGE
Target $393
GSCO
Neutral
Boeing price target lowered to $393 from $420 at Goldman Sachs
Goldman Sachs analyst Noah Poponak lowered his price target on Boeing to $393 and kept his Neutral rating, saying he has been surprised by the "benign expected set of scenarios" by investors as the company investigates the recent 737 MAX events. In his conversations with investors, there seems to be "minimal overall concern with medium to long term earnings and free cash estimates" for Boeing as investors expect the company to figure out the software fix relatively quickly, the analyst writes in his research note. Poponak states however that these assumptions carry some risk, with a "non-zero chance of more than a software change given the structural changes to the airplane made for the MAX vs. the NG" model", and could impact longer-lasting impact on Boeing's 737 MAX aircraft demand.
04/10/19
JPMS
04/10/19
NO CHANGE
Target $430
JPMS
Overweight
Boeing price target lowered to $430 from $450 at JPMorgan
JPMorgan analyst Seth Seifman lowered his price target for Boeing to $430 from $450 after updating his model for the company's "roughly in line" Q1 deliveries. However, "at this stage, modeling Boeing requires major assumptions for which there is little basis right now," Seifman tells investors in a research note. Uncertainties center around the span of the MAX delivery halt, how quickly Boeing might flush out MAX inventory when the halt is lifted, and how management plans to guide with Q1 results, says the analyst. He keeps an Overweight rating on Boeing shares.
04/11/19
04/11/19
NO CHANGE

Boeing CEO says conducted 100 test flights with fixed 737 MAX software, WSJ says
The Wall Street Journal's Andrew Tangel reports that Boeing CEO Dennis Muilenburg, making his first public remarks since the Ethiopian Airlines crash of 737 MAX last month, indicated that the software changes being made will make the aircraft "even safer". Muilenburg noted that Boeing engineers have been "working tirelessly in collaboration with the Federal Aviation Administration to finalize and implement a software update that will ensure accidents like these never happen again". The CEO added that the company has already conducted nearly 100 test flights of the fixed 737 MAX software since it grounded the aircraft last month. Reference Link
04/18/19
WBLR
04/18/19
INITIATION
WBLR
Outperform
Woodward initiated with an Outperform at William Blair
William Blair analyst Nicholas Heymann started Woodward (WWD) with an Outperform rating saying the stock offers 15%-20% upside over the next 6-12 months. After six years of "robust" investment for new capacity and products, Woodward is entering a period of accelerating profitable organic growth. He believes the company is "exceptionally well positioned" to generate "sustainable" double-digit earnings growth despite the current Boeing (BA) 737 Max grounding.
I Intelsat
$19.38

0.14 (0.73%)

04/03/19
JPMS
04/03/19
UPGRADE
Target $27
JPMS
Overweight
Intelsat upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Philip Cusick upgraded Intelsat to Overweight from Neutral with a $27 price target. The analyst a C-band spectrum sale as the most likely course for the company.
04/03/19
JPMS
04/03/19
UPGRADE
Target $27
JPMS
Overweight
JPMorgan upgrades Intelsat to Overweight ahead of expected spectrum sales
JPMorgan analyst Philip Cusick upgraded Intelsat to Overweight from Neutral with an unchanged price target of $27. The stock has declined 28% year-to-date and 38% since February 27 when a "slew of headlines all but halted" the C-Band Alliance's momentum in D.C., Cusick tells investors in a research note. However, after being overly-optimistic in the fall, the market is now "underpricing the likelihood" of Intelsat and the C-Band Alliance eventually selling spectrum and "reaping substantial proceeds," says the analyst. Cusick believes the alliance still has the support of key decision makers at the Federal Communications Commission and that some version of a market-based approach is the most likely path to get C-Band spectrum into the hands of wireless carriers in the next five years.
04/03/19
04/03/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Urban Outfitters (URBN) upgraded to Buy from Neutral at DA Davidson with analyst John Morris saying the data showcase the company's "green shoots in improving pricing architecture at the Anthropologie division with stronger pricing and lower markdown cadence at the Urban division." 2. Intelsat (I) upgraded to Overweight from Neutral at JPMorgan with analyst Philip Cusick saying the stock has declined 28% year-to-date and 38% since February 27 when a "slew of headlines all but halted" the C-Band Alliance's momentum in D.C. 3. e.l.f. Beauty (ELF) upgraded to Buy from Hold at Jefferies with analyst Stephanie Wissink saying he believes the company's improved merchandising focus will drive a "meaningful reversal" in sales trends. 4. Enterprise Products (EPD) upgraded to Buy from Neutral at Goldman Sachs with analyst Michael Lapides citing the company's improving cash flow, exposure to key themes that include a "leading position in crude oil and NGL exports," and its position as "one of the more integrated infrastructure portfolios within the sector," extending its footprint "further downstream than most midstream companies." 5. CommScope (COMM) upgraded to Strong Buy from Outperform at Raymond James with analyst Simon Leopold saying he believes the earnings accretion from the pending Arris (ARRS) acquisition is underappreciated and will provide at least 40% accretion versus management's forecast for over 30% and analyst estimates of 25%-43%. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/17/19
GSCO
04/17/19
NO CHANGE
GSCO
Sprint, T-Mobile headlines positive for Dish, Intelsat, says Goldman Sachs
Goldman Sachs analyst Brett Feldman, while taking no view on the outcome of the proposed merger between Sprint (S) and T-Mobile (TMUS), laid out his thoughts for other industry participants following the Wall Street Journal's report that the Department of Justice is unlikely to approve the deal as currently structured. The analyst believes investors will initially see the headlines as negative for the other major wireless carriers, namely AT&T (T) and Verizon (VZ), since they "create uncertainty over long-term industry structure." Further, investors will initially see these headlines as a slight positive for tower operators American Tower (AMT), Crown Castle (CCI) and SBA Communications (SBAC) as they "imply less risk of material cell site decommissioning," Feldman told investors earlier in a research note. The analyst also thinks investors will view the Journal's report as positive for owners of excess spectrum such as Dish (DISH) and Intelsat (I) and a slight positive for cable operators like Altice USA (ATUS), Charter (CHTR) and Comcast (CMCSA).

TODAY'S FREE FLY STORIES

AJG

Arthur J. Gallagher

$94.63

0.16 (0.17%)

08:39
12/13/19
12/13
08:39
12/13/19
08:39
Conference/Events
Arthur J. Gallagher to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

NEWR

New Relic

$66.87

0.86 (1.30%)

08:38
12/13/19
12/13
08:38
12/13/19
08:38
Recommendations
New Relic analyst commentary  »

Morgan Stanley came way…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMK

AssetMark Financial

$27.31

0.42 (1.56%)

08:38
12/13/19
12/13
08:38
12/13/19
08:38
Upgrade
AssetMark Financial rating change  »

JPMorgan upgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LII

Lennox

$259.14

0.71 (0.27%)

08:38
12/13/19
12/13
08:38
12/13/19
08:38
Conference/Events
Lennox to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

VIAC

ViacomCBS

$37.79

0.52 (1.40%)

08:36
12/13/19
12/13
08:36
12/13/19
08:36
Initiation
ViacomCBS initiated  »

ViacomCBS reinstated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLRB

Cellectar Biosciences

$2.23

0.12 (5.69%)

08:35
12/13/19
12/13
08:35
12/13/19
08:35
Hot Stocks
Cellectar Biosciences presents data on CLR 2000045 at AACR symposium »

Cellectar Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OCFT

OneConnect

$0.00

(0.00%)

08:35
12/13/19
12/13
08:35
12/13/19
08:35
Syndicate
OneConnect 31.2M share IPO priced at $10.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

ONCS

OncoSec

$2.39

-0.04 (-1.65%)

, MRK

Merck

$88.95

0.6 (0.68%)

08:34
12/13/19
12/13
08:34
12/13/19
08:34
Hot Stocks
OncoSec reports interim results from KEYNOTE-890 study »

OncoSec announced interim…

ONCS

OncoSec

$2.39

-0.04 (-1.65%)

MRK

Merck

$88.95

0.6 (0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 24

    Jan

  • 24

    Jan

  • 05

    Feb

  • 14

    Mar

CFX

Colfax

$35.74

0.6 (1.71%)

08:34
12/13/19
12/13
08:34
12/13/19
08:34
Conference/Events
Colfax to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

SRPT

Sarepta

$100.39

-1.15 (-1.13%)

08:33
12/13/19
12/13
08:33
12/13/19
08:33
Hot Stocks
Sarepta announces $250M of non-dilutive senior secured loan financing »

Sarepta Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$305.76

2.01 (0.66%)

08:33
12/13/19
12/13
08:33
12/13/19
08:33
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

ATNX

Athenex

$16.94

-0.36 (-2.08%)

08:32
12/13/19
12/13
08:32
12/13/19
08:32
Hot Stocks
Athenex announces results from Phase III trial of oral paclitaxel »

Athenex announced results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

PFE

Pfizer

$38.54

0.3 (0.78%)

08:32
12/13/19
12/13
08:32
12/13/19
08:32
Hot Stocks
Pfizer announces CHMP recommendation for approval of Vyndaqel »

Pfizer announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TREE

LendingTree

$293.67

-13 (-4.24%)

08:31
12/13/19
12/13
08:31
12/13/19
08:31
Recommendations
LendingTree analyst commentary  »

LendingTree price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNM

Unum Group

$31.01

0.82 (2.72%)

08:30
12/13/19
12/13
08:30
12/13/19
08:30
Conference/Events
Unum Group to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

08:30
12/13/19
12/13
08:30
12/13/19
08:30
Options
One option delisting on December 13th »

Option delistings…

08:25
12/13/19
12/13
08:25
12/13/19
08:25
Conference/Events
Federal Reserve Bank of New York president participates in a discussion »

New York Federal Reserve…

FORM

FormFactor

$24.96

1.19 (5.01%)

, INTC

Intel

$57.56

0.52 (0.91%)

08:25
12/13/19
12/13
08:25
12/13/19
08:25
Recommendations
FormFactor, Intel, Samsung, TSMC analyst commentary  »

FormFactor price target…

FORM

FormFactor

$24.96

1.19 (5.01%)

INTC

Intel

$57.56

0.52 (0.91%)

SSNLF

Samsung

$0.00

(0.00%)

TSM

TSMC

$58.61

2.71 (4.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 23

    Jan

$DJT

DJ Transportation Average

$0.00

(0.00%)

08:24
12/13/19
12/13
08:24
12/13/19
08:24
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJU

DJ Utility Average

$0.00

(0.00%)

08:24
12/13/19
12/13
08:24
12/13/19
08:24
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

08:24
12/13/19
12/13
08:24
12/13/19
08:24
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAS

Masco

$47.44

1 (2.15%)

, FBHS

Fortune Brands

$65.51

0.31 (0.48%)

08:24
12/13/19
12/13
08:24
12/13/19
08:24
Recommendations
Masco, Fortune Brands analyst commentary  »

Masco, Fortune Brands…

MAS

Masco

$47.44

1 (2.15%)

FBHS

Fortune Brands

$65.51

0.31 (0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYT

iShares Transportation Average

$194.19

2.09 (1.09%)

08:24
12/13/19
12/13
08:24
12/13/19
08:24
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLK

Technology Select Sector SPDR

$88.89

0.9 (1.02%)

08:23
12/13/19
12/13
08:23
12/13/19
08:23
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$60.86

1.19 (1.99%)

08:23
12/13/19
12/13
08:23
12/13/19
08:23
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.